Kathrin Schanda

7.3k total citations · 1 hit paper
46 papers, 2.8k citations indexed

About

Kathrin Schanda is a scholar working on Pathology and Forensic Medicine, Neurology and Immunology. According to data from OpenAlex, Kathrin Schanda has authored 46 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pathology and Forensic Medicine, 24 papers in Neurology and 13 papers in Immunology. Recurrent topics in Kathrin Schanda's work include Multiple Sclerosis Research Studies (32 papers), Peripheral Neuropathies and Disorders (20 papers) and T-cell and B-cell Immunology (8 papers). Kathrin Schanda is often cited by papers focused on Multiple Sclerosis Research Studies (32 papers), Peripheral Neuropathies and Disorders (20 papers) and T-cell and B-cell Immunology (8 papers). Kathrin Schanda collaborates with scholars based in Austria, Germany and Italy. Kathrin Schanda's co-authors include Markus Reindl, Thomas Berger, Kevin Rostásy, Nadia Stefanova, Simone Mader, Lars Klimaschewski, Gregor K. Wenning, Werner Poewe, Regina Irschick and Lisa Fellner and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Neurology.

In The Last Decade

Kathrin Schanda

44 papers receiving 2.7k citations

Hit Papers

Toll‐like receptor 4 is required for α‐synuclein dependen... 2012 2026 2016 2021 2012 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Toll‐like receptor 4 is required for α‐synuclein dependent activation of microglia and astroglia
    2012 553 citations Regina Irschick, Kathrin Schanda et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathrin Schanda Austria 23 1.7k 1.6k 588 560 422 46 2.8k
Simone Mader Germany 23 1.6k 0.9× 1.6k 1.1× 532 0.9× 740 1.3× 490 1.2× 39 2.8k
Noriko Isobe Japan 25 974 0.6× 1.3k 0.8× 316 0.5× 546 1.0× 510 1.2× 129 2.4k
Yoshiki Takai Japan 23 1.6k 0.9× 1.9k 1.2× 327 0.6× 586 1.0× 384 0.9× 118 2.6k
Bogdan F. Gh. Popescu Canada 18 885 0.5× 1.3k 0.8× 373 0.6× 338 0.6× 454 1.1× 22 2.0k
Markus Axelsson Sweden 26 892 0.5× 1.7k 1.1× 358 0.6× 376 0.7× 657 1.6× 80 2.7k
Douglas Kazutoshi Sato Brazil 28 2.2k 1.3× 2.5k 1.6× 295 0.5× 943 1.7× 371 0.9× 85 3.2k
Barbara Kornek Austria 20 732 0.4× 1.7k 1.1× 515 0.9× 357 0.6× 557 1.3× 58 2.5k
Pierre Labauge France 23 1.2k 0.7× 506 0.3× 300 0.5× 344 0.6× 716 1.7× 119 2.4k
José Boucraut France 31 876 0.5× 399 0.3× 347 0.6× 282 0.5× 625 1.5× 97 2.8k
Davorka Tomic Switzerland 26 836 0.5× 1.9k 1.2× 207 0.4× 388 0.7× 600 1.4× 87 2.5k

Countries citing papers authored by Kathrin Schanda

Since Specialization
Citations

This map shows the geographic impact of Kathrin Schanda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathrin Schanda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathrin Schanda more than expected).

Fields of papers citing papers by Kathrin Schanda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathrin Schanda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathrin Schanda. The network helps show where Kathrin Schanda may publish in the future.

Co-authorship network of co-authors of Kathrin Schanda

This figure shows the co-authorship network connecting the top 25 collaborators of Kathrin Schanda. A scholar is included among the top collaborators of Kathrin Schanda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathrin Schanda. Kathrin Schanda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schanda, Kathrin, Sara Mariotto, Dagmar Rudzki, et al.. (2024). Is there an immunological cross-reactivity of antibodies to the myelin oligodendrocyte glycoprotein and coronaviruses?. Brain Communications. 6(2). fcae106–fcae106. 1 indexed citations
2.
Dinoto, Alessandro, Markus Reindl, Kathrin Schanda, et al.. (2022). Peripheral neuropathy and MOG-IgG: A clinical and neuropathological retrospective study. Multiple Sclerosis and Related Disorders. 68. 104214–104214. 8 indexed citations
3.
Mariotto, Sara, Matteo Gastaldi, Luisa Grazian, et al.. (2021). NfL levels predominantly increase at disease onset in MOG-Abs-associated disorders. Multiple Sclerosis and Related Disorders. 50. 102833–102833. 20 indexed citations
4.
Pauli, Franziska Di, Klaus Berek, Michael Auer, et al.. (2021). Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and Varicella Zoster Virus Infection - Frequency of an Association. Frontiers in Immunology. 12. 769653–769653. 6 indexed citations
5.
Carta, Sara, Romana Höftberger, Silvia Bozzetti, et al.. (2021). Antibodies to MOG in CSF only: pathological findings support the diagnostic value. Acta Neuropathologica. 141(5). 801–804. 14 indexed citations
6.
Lechner, Christian, Markus Breu, Eva‐Maria Wendel, et al.. (2020). Epidemiology of Pediatric NMOSD in Germany and Austria. Frontiers in Neurology. 11. 415–415. 10 indexed citations
7.
Peschl, Patrick, Kathrin Schanda, Bleranda Zeka, et al.. (2017). Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelination. Journal of Neuroinflammation. 14(1). 208–208. 119 indexed citations
8.
Mariotto, Sara, Alessia Farinazzo, Salvatore Monaco, et al.. (2017). Serum Neurofilament Light Chain in NMOSD and Related Disorders: Comparison According to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies Status. Multiple Sclerosis Journal - Experimental Translational and Clinical. 3(4). 2452163066–2452163066. 31 indexed citations
9.
Schanda, Kathrin, Romana Höftberger, Michael Khalil, et al.. (2016). Characterization of the binding pattern of human aquaporin-4 autoantibodies in patients with neuromyelitis optica spectrum disorders. Journal of Neuroinflammation. 13(1). 176–176. 16 indexed citations
10.
Zeka, Bleranda, Maria Hastermann, Sonja Hochmeister, et al.. (2015). Highly encephalitogenic aquaporin 4-specific T cells and NMO-IgG jointly orchestrate lesion location and tissue damage in the CNS. Acta Neuropathologica. 130(6). 783–798. 57 indexed citations
11.
Ramberger, Melanie, Patrick Peschl, Kathrin Schanda, et al.. (2015). Comparison of Diagnostic Accuracy of Microscopy and Flow Cytometry in Evaluating N-Methyl-D-Aspartate Receptor Antibodies in Serum Using a Live Cell-Based Assay. PLoS ONE. 10(3). e0122037–e0122037. 22 indexed citations
12.
Peschl, Patrick, Markus Reindl, Kathrin Schanda, et al.. (2014). Antibody responses following induction of antigen-specific tolerance with antigen-coupled cells. Multiple Sclerosis Journal. 21(5). 651–655. 9 indexed citations
13.
Dujmović, Irena, Simone Mader, Kathrin Schanda, et al.. (2011). Temporal dynamics of cerebrospinal fluid anti-aquaporin-4 antibodies in patients with neuromyelitis optica spectrum disorders. Journal of Neuroimmunology. 234(1-2). 124–130. 38 indexed citations
14.
Schanda, Kathrin, Martin Hermann, Nadia Stefanova, et al.. (2011). Nogo-B is associated with cytoskeletal structures in human monocyte-derived macrophages. BMC Research Notes. 4(1). 6–6. 19 indexed citations
15.
Mader, Simone, Viktoria Gredler, Kathrin Schanda, et al.. (2011). Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. Journal of Neuroinflammation. 8(1). 184–184. 347 indexed citations
16.
Pauli, Franziska Di, Simone Mader, Kevin Rostásy, et al.. (2010). Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases. Clinical Immunology. 138(3). 247–254. 142 indexed citations
17.
Mader, Simone, Andreas Lutterotti, Franziska Di Pauli, et al.. (2010). Patterns of Antibody Binding to Aquaporin-4 Isoforms in Neuromyelitis Optica. PLoS ONE. 5(5). e10455–e10455. 127 indexed citations
18.
Ehrlenbach, Silvia, Peter Willeit, Stefan Kiechl, et al.. (2009). Influences on the reduction of relative telomere length over 10 years in the population-based Bruneck Study: introduction of a well-controlled high-throughput assay. International Journal of Epidemiology. 38(6). 1725–1734. 152 indexed citations
19.
Reindl, Markus, Rainer Ehling, Kathrin Schanda, et al.. (2003). Serum and cerebrospinal fluid antibodies to Nogo-A in patients with multiple sclerosis and acute neurological disorders. Journal of Neuroimmunology. 145(1-2). 139–147. 58 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simone Mader Breakdown of academic impact, for papers by Noriko Isobe Breakdown of academic impact, for papers by Yoshiki Takai Breakdown of academic impact, for papers by Bogdan F. Gh. Popescu Breakdown of academic impact, for papers by Markus Axelsson Breakdown of academic impact, for papers by Douglas Kazutoshi Sato Breakdown of academic impact, for papers by Barbara Kornek Breakdown of academic impact, for papers by Pierre Labauge Breakdown of academic impact, for papers by José Boucraut Breakdown of academic impact, for papers by Davorka Tomic
Rankless by CCL
2026